Stock Detail
NUVASIVE INC
Indices SP 600
NUVA @ Yahoo Finance | NUVA Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $14.58 | $15.00 | $-0.40 | -2.67% | 0.00 | $14.98 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $14.77 | $14.45 | 406,251 | 615.92M | 1.04M | -107.02 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 15.23 | 14.91 | 14.68 | 14.36 | 14.13 |
Stock Profile
NuVasive, Inc., a medical device company, focuses on the design, development, and marketing of products for the surgical treatment of spine disorders in the United States. The company's principal products include a minimally disruptive surgical platform called maximum access surgery (MAS) and classic fusion products. The MAS platform combines its product offerings, NeuroVision, a proprietary software-driven nerve avoidance system; MaXcess, a split blade-design minimally invasive surgical system; and specialized implants—that collectively minimize soft tissue disruption during spine surgery. NuVasive's classic fusion portfolio is comprised of a range of products, including spine allografts, which are human bone that has been processed and precision shaped for transplant; and spine implants such as rods, plates, and screws that are necessary for various spine surgery procedures. The company is also developing a proprietary total lateral lumbar disc replacement product and cervical disc replacement product. NuVasive sells its products through its sales agencies and representatives to hospitals. The company was founded in 1995 and is headquartered in San Diego, California.